A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
Clinical trial NCT06844357 · RECRUITING
Trial details
- NCT number
- NCT06844357
- Sponsor
- Zhejiang Raygene Pharmaceuticals Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2029-04-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.